David Georges
Director of Finance/CFO at CELYAD ONCOLOGY SA
Network origin in David Georges first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David Georges via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Investment Banks/Brokers | Corporate Officer/Principal | |
| SOLVAY SA | Chemicals: Specialty | General Counsel | |
| Cayuga MBA Fund LLC | Corporate Officer/Principal | ||
| VOLCANO CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ANAPTYSBIO, INC. | Biotechnology | Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Virginia | College/University | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree | |
| DELHAIZE GROUP | Food Retail | General Counsel | |
| University of Leeds | College/University | Doctorate Degree | |
| Syracuse University | College/University | Undergraduate Degree | |
| Hofstra University | College/University | Masters Business Admin | |
| Yale University | College/University | Corporate Officer/Principal Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin | |
| St. John's University | College/University | Graduate Degree | |
| University Of Dundee | College/University | Doctorate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Chief Operating Officer | |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Analyst | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fourcroy SA
 Fourcroy SA Food DistributorsDistribution Services Fourcroy SA wholesales wine and distilled beverages. Fourcroy distributor of this broad portfolio of wines and spirits in Belgium and the Grand Duchy of Luxembourg may rely on the experience and innovative ideas. The company was founded in 1862 and is headquartered in Braine-L'Alleud, Belgium. | Food Distributors | Corporate Officer/Principal | |
| MEDIVATION INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Université Libre de Bruxelles | College/University | Graduate Degree Corporate Officer/Principal | |
| ESSEC Business School | College/University | Graduate Degree | |
| University of Crete | College/University | Doctorate Degree | |
Linklaters de Bandt
 Linklaters de Bandt Miscellaneous Commercial ServicesCommercial Services Part of Linklaters LLP, Linklaters de Bandt is a Belgian company that provides legal services. The private company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MedPole SA/NV | Chief Executive Officer Chief Operating Officer | ||
| Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree | |
| Astellas Pharmaceuticals SA | Corporate Officer/Principal | ||
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Chief Executive Officer | |
| Harvard Law School | College/University | Graduate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
PetSerCo BV
 PetSerCo BV Financial ConglomeratesFinance PetSerCo BV operates as an investment vehicle. The company is headquartered in Wavre, Belgium. | Financial Conglomerates | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Cellular Therapeutics Ltd.
 Cellular Therapeutics Ltd. BiotechnologyHealth Technology Part of Instil Bio, Inc., Cellular Therapeutics Ltd. is a British company that manufactures cell therapy products. The private company is based in Manchester, UK. The company was founded by David Gilham. | Biotechnology | Founder | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member | |
| Nouscom Srl | Miscellaneous Commercial Services | Chief Executive Officer | |
| Boston University School of Medicine | College/University | Doctorate Degree |
Statistics
International
| United States | 28 |
| Belgium | 9 |
| United Kingdom | 5 |
| France | 5 |
| Switzerland | 3 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 17 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 67 |
| Corporate Officer/Principal | 39 |
| Chief Executive Officer | 21 |
| Chief Tech/Sci/R&D Officer | 14 |
| Independent Dir/Board Member | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Michel Lussier | 20 |
| Serge Goblet | 20 |
| Hilde Windels | 18 |
| Maria Koehler | 11 |
| Charles Q. Morris | 10 |
| Stephen Rubino | 10 |
| Margo Roberts | 10 |
| Philippe Dechamps | 10 |
| Christian Homsy | 9 |
| Filippo Petti | 9 |
| Dominic Piscitelli | 7 |
| J. Christopher LiPuma | 7 |
| Marina Udier | 6 |
| Georges Rawadi | 5 |
| Philippe Nobels | 5 |
- Stock Market
- Insiders
- David Georges
- Company connections